Free Trial

iRhythm Technologies (IRTC) Competitors

iRhythm Technologies logo
$139.71 -2.77 (-1.94%)
As of 03:27 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRTC vs. ZBH, SNN, SOLV, PEN, STVN, GKOS, NARI, TMDX, BLCO, and SLNO

Should you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

iRhythm Technologies vs. Its Competitors

iRhythm Technologies (NASDAQ:IRTC) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

In the previous week, Zimmer Biomet had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 14 mentions for Zimmer Biomet and 6 mentions for iRhythm Technologies. Zimmer Biomet's average media sentiment score of 1.21 beat iRhythm Technologies' score of 0.89 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Zimmer Biomet
11 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

88.9% of Zimmer Biomet shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Zimmer Biomet has a net margin of 11.86% compared to iRhythm Technologies' net margin of -15.90%. Zimmer Biomet's return on equity of 12.73% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-15.90% -101.04% -9.55%
Zimmer Biomet 11.86%12.73%7.34%

iRhythm Technologies currently has a consensus target price of $138.60, suggesting a potential downside of 1.06%. Zimmer Biomet has a consensus target price of $111.33, suggesting a potential upside of 20.34%. Given Zimmer Biomet's higher probable upside, analysts clearly believe Zimmer Biomet is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90
Zimmer Biomet
2 Sell rating(s)
10 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.30

iRhythm Technologies has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.

Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$591.84M7.56-$113.29M-$3.14-44.61
Zimmer Biomet$7.68B2.38$903.70M$4.5220.47

Summary

Zimmer Biomet beats iRhythm Technologies on 12 of the 16 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRTC vs. The Competition

MetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$4.47B$1.93B$5.45B$8.93B
Dividend YieldN/AN/A5.22%4.00%
P/E Ratio-44.6135.2627.3320.08
Price / Sales7.5615.42426.87118.59
Price / CashN/A55.8726.2128.59
Price / Book48.318.557.935.60
Net Income-$113.29M-$62.39M$3.17B$248.65M
7 Day Performance-9.01%1.70%4.55%7.33%
1 Month Performance-4.49%1.69%2.71%8.27%
1 Year Performance40.78%5.01%35.01%21.79%

iRhythm Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRTC
iRhythm Technologies
1.055 of 5 stars
$139.71
-1.9%
$138.60
-0.8%
+43.1%$4.47B$591.84M-44.582,000
ZBH
Zimmer Biomet
4.8795 of 5 stars
$91.23
-0.3%
$111.53
+22.2%
-13.3%$18.10B$7.68B11.6217,000Positive News
SNN
Smith & Nephew SNATS
3.0819 of 5 stars
$30.67
+1.5%
$28.00
-8.7%
+12.9%$13.24B$5.81B14.2017,349
SOLV
Solventum
0.8189 of 5 stars
$75.81
+0.5%
$80.29
+5.9%
+56.1%$13.06B$8.25B13.8222,000Positive News
PEN
Penumbra
4.678 of 5 stars
$256.00
-0.2%
$302.40
+18.1%
+38.4%$9.93B$1.19B77.944,500
STVN
Stevanato Group
N/A€24.51
-0.5%
N/A+32.7%€7.42B€1.19B48.065,521
GKOS
Glaukos
4.5483 of 5 stars
$103.42
+2.0%
$134.67
+30.2%
-15.0%$5.80B$383.48M0.00780Positive News
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.5666 of 5 stars
$134.01
+1.9%
$127.33
-5.0%
-15.5%$4.45B$441.54M96.65210Positive News
BLCO
Bausch + Lomb
2.9402 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-6.0%$4.39B$4.79B25.8313,500High Trading Volume
SLNO
Soleno Therapeutics
4.4614 of 5 stars
$83.78
+0.6%
$107.10
+27.8%
+111.8%$4.20BN/A0.0030

Related Companies and Tools


This page (NASDAQ:IRTC) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners